BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8437840)

  • 1. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
    Maher DW; Strawn LM; Donoghue DJ
    Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
    Potapova O; Fakhrai H; Baird S; Mercola D
    Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor.
    Funa K; Uramoto H
    Acta Biochim Pol; 2003; 50(3):647-58. PubMed ID: 14515146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
    Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
    J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterization of small random transmembrane proteins that bind and activate the platelet-derived growth factor beta receptor.
    Freeman-Cook LL; Dixon AM; Frank JB; Xia Y; Ely L; Gerstein M; Engelman DM; DiMaio D
    J Mol Biol; 2004 May; 338(5):907-20. PubMed ID: 15111056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor: roles in normal and v-sis transformed cells.
    Deuel TF; Kimura A; Maehama S; Tong BD
    Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor in human malignancy.
    Silver BJ
    Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
    Riese DJ; DiMaio D
    Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
    Petti LM; Reddy V; Smith SO; DiMaio D
    J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sis gene and PDGF.
    Williams LT
    Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces.
    Adduci AJ; Schlegel R
    J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nonessential disulfide bonds and altered conformations in the v-sis protein, a homolog of the B chain of platelet-derived growth factor.
    Sauer MK; Donoghue DJ
    Mol Cell Biol; 1988 Mar; 8(3):1011-8. PubMed ID: 2835654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
    Kujoth GC; Fahl WE
    Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H; Fredriksson L; Li X; Eriksson U
    Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of coatomer proteins with the beta-receptor for platelet-derived growth factor.
    Hansen K; Rönnstrand L; Rorsman C; Hellman U; Heldin CH
    Biochem Biophys Res Commun; 1997 Jun; 235(3):455-60. PubMed ID: 9207175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor in human glioma.
    Westermark B; Heldin CH; Nistér M
    Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
    Meyer AN; Xu YF; Webster MK; Smith AE; Donoghue DJ
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4634-8. PubMed ID: 8197111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural models of the bovine papillomavirus E5 protein.
    Surti T; Klein O; Aschheim K; DiMaio D; Smith SO
    Proteins; 1998 Dec; 33(4):601-12. PubMed ID: 9849943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.